June 25, 2020
APAC Town Hall: The New Competencies Required for MA Professionals to Excel in the New Environment
In this APAC Town Hall, senior leaders discuss: Managing Individual Performance Remotely; Virtual Leadership Mindset & Skills; Effective Team Engagement in the Virtual Space; Engagement of KOLs Virtually
June 15, 2020
Contemporary Practices for Data Generation Strategies: Design, Implementation, and Communication of New Evidence
Join this Webinar to better understand contemporary practices for data generation strategies; describe how to design data generation strategies, implementation of the strategies, and how to communicate new evidence; and describe how real-world evidence may be utilized to support product value including regulatory label change.
May 22, 2020
Converting Challenges Into Opportunities While Building Your Scientific Communication Platform
The scientific communication platform (SCP) forms the core for all communications about a product and serves as the repository of available evidence and statements to support Medical Affairs strategy. Join us for this Webinar on Converting Challenges Into Opportunities While Building Your SCP.
April 22, 2020
COVID-19 – A MAPS Global Town Hall: Best Practices & the Future of Medical Affairs
Miss the live town hall? View the on-demand version here as senior leaders from 6 companies discuss how Medical Affairs is functioning during the COVID-19 pandemic, share best practices, and look to the future of MA post-COVID-19. OPEN ACCESS: membership is not required to view.
May 9, 2020
COVID-19 – A MAPS APAC Region Town Hall: Best Practices & the Future of Medical Affairs
Miss the live town hall? View the on-demand version here as senior leaders from 5 companies across the APAC region discuss how Medical Affairs is functioning during the COVID-19 pandemic, share best practices, and look to the future of MA post-COVID-19. OPEN ACCESS: membership is not required to view.
April 29, 2020
External Medical Education: Responding to the Challenges of COVID-19 and Planning for the Future
The COVID-19 pandemic is changing the External Education landscape for healthcare stakeholders and creating new challenges for the future. Join an expert panel of industry leaders as they examine the current impact of COVID-19 on External Education programs and review considerations for future planning.
June 3, 2020
Impact of COVID-19 on Global MA Compliance Panel
Join expert panelists on this Webinar to better understand compliance implications of the changing business models during and post-COVID, and identify Medical Affairs compliance risks and mitigation strategies.
April 8, 2020
Launch Readiness 2020: Ensuring Strategy and Value from Global to Local Perspectives
What is Strategy Related to Launch? Topics addressed in this Webinar include: What is the role for Medical Affairs in launch readiness? Who is part of launch readiness and how is it accomplished? How do local affiliates impact the global strategy? What performance measures (KPIs) can we use to refine strategy?
November 6, 2019
Will Customer Experiences Shape the Future of Medical Affairs?
Understand digital trends seen within Medical Affairs today as well as be aware of why HCP expectations are changing and how to evolve with them to provide better customer experiences.
October 31, 2019
Accelerating Insights to Impact: Best Practices for Medical Insights
In this webinar, we advance a set of standards that Medical Affairs leaders can use as a starting point to customize and develop cutting-edge Medical insights processes for their own organizations.
October 30, 2019
How to Measure the Impact (Contribution) of Medical Affairs to the Organization
Understand the different levels of Medical Affairs (MA) impact and what MA professionals need to do to succeed; Be able to demonstrate and articulate the value of field medical to the organization; understand the importance of quantitative and qualitative field medical metrics in telling this value story
October 20, 2019
Creating an Integrated Core Scientific Framework for Communicating to Diverse External Stakeholders: A Health Science Approach
Evaluate the commonalities and differences in the use, structure and evolution of scientific communications platforms within and between companies; understand how a HealthScience approach can help to integrate insights, communications and evidence generation plans across multiple functions
September 19, 2019
How to Build a Successful Career as a Medical Affairs Professional
“Insider tips” from three senior-level Medical Affairs leaders from leading multinational biopharma companies. The discussion will be broken into three practical sections: 1. How to advance your career in Medical Affairs; 2. What employers look for when hiring; 3. Competencies required for a modern Medical Affairs organization.
September 12, 2019
Medical Affairs Strategic Planning: Providing a Roadmap for Success
An intro to strategic planning principles that can be employed to develop a successful medical plan; understand the value of having a thoughtful Medical plan; identify critical success factors and potential pitfalls in developing a strategic Medical plan; work with the MAPS Standards and Guidance Medical Affairs Strategic Plan template and guide.
September 5, 2019
Understanding AI and ML and Potential Applications For Medical Affairs
Understand the latest technologies—Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU), and their potential to increase efficiencies, enhance effectiveness and potentially reduce compliance risk.
August 21, 2019
Evolving How Medical Affairs Informs Strategic Planning
Understand how to utilize an informed approach to decision making to drive the strategic planning process; gain insight into the value data can bring to Medical Affairs during strategic planning cycles throughout the year; obtain a working knowledge of how cross-functional teams within Medical Affairs can apply insights gleaned from data to enhance utilization and the impact of efforts
August 14, 2019
The ABCs of DOLs (Digital Opinion Leaders): Identification, Monitoring, and Engagement
This Webinar provides perspectives on the evolving role of Digital Opinion Leaders in medical education and shares approaches for identifying, monitoring and engaging them in a compliant manor with relevant examples.
July 31, 2019
Building Capabilities for a Future Proof Medical Department
MAPS and McKinsey and Co. leadership discuss questions such as: Where MA capabilities need to be in the future; what are the obstacles to building capabilities more quickly? what behaviors and mindsets need to change besides just learning the knowledge? why is capability building important to MAPS, and what is MAPS doing going forward? How can we address capability gaps as MA professionals and leaders within our own organizations?
May 29, 2019
How Medical Affairs Physicians Can Help to Provide Leadership and Solutions that Will Create a Better, More Sustainable and Higher Value Health System
In this offering, we bring together a roundtable of innovative leaders from the payer, pharmaceutical, medical device, provider (Integrated Delivery Networks) and consumer/purchaser sectors to discuss some of the challenging problems and opportunities in this space.
March 27, 2019
Clinical Statistics for Non-Statisticians (Part 2 of 2)
Part 2 of this series will discuss statistical analysis in clinical trials including null/alternative hypotheses; statistical assumptions (type I error, significance level, type II error, statistical power); hypothesis testing; Statistics used in RCTs, including type of outcome measures, analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves).
March 27, 2019
A Global Perspective on Conducting Early Access Programs
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.
October 24, 2018
Clinical Statistics for Non-Statisticians (Part 1 of 2)
Part 1 of this series will: define terminologies in statistics; explain different types of data (quantitative vs. qualitative); describe different ways in presenting summary data (such as proportions, means, medians, range and standard deviation); explain 95% confidence intervals; discuss bivariate analyses and appropriate statistical testing for quantitative and qualitative variables
February 6, 2019
Patient Engagement in Drug Development: An Opportunity for Medical Affairs
Understand the numerous ways in which partnership with patients can impact the development and commercialization of medicines; the current “patient centric” landscape in pharmaceutical drug development; recent findings related to the value of patient-centric trial design, and innovative approaches to engaging with patients across the study continuum.
October 10, 2018
Value Assessment for Health Technologies – A Primer on Cost-Effectiveness Analysis and Health Technology Assessment
Health technology and value assessment can be conducted using a variety of methods. Dr. Malone will provide an overview of those methods and an introduction on how to interpret the results from cost-effectiveness studies. This webinar will also discuss issues with defining value for health technologies, especially pharmaceuticals.
November 28, 2018
Field Based Medical LCM in the Device and Pharma World
MSLs are becoming more important and playing key roles across the lifecycle in partnership with many others who play important roles. We will describe the landscape, drivers, and opportunities for engaging with customers across the lifecycle and how we socialize learnings across the organization.
October 30, 2018
Dust Off Your Scientific Communication Platforms: Updating, Implementing, and Operationalizing Them for Success
Ensure understanding of the basic components and processes involved in the development of a scientific communication platform (SCP); how to develop and/or update an SCP so that the scientific and value narratives are integrated; learn how to train and implement an SCP across functional teams; glean insights into tailoring a global SCP to a regional SCP
September 28, 2018
Truth Hunting: Leave No Stone Unturned in Defining Impactful Medical Affairs Strategies
Look beyond the traditional elements of landscape analysis to consider valuable cultural, behavioral, and situational insights; understand the power of truths in defining the meaningful difference your product will make in patients’ lives; understand the key ingredients of a robust and impactful Medical Affairs strategy and how to implement it.
September 18, 2018
“MSLs Rattling the Cage” – break out roles, strategic innovation and building excellence for Field Based Medical
Gain tips and tricks for communicating cross-functionally the value of Field Based Medical; enhance your business acumen and ability to leverage the business through science and effective strategy; learn about demonstration of value and how to measure it and to hire, train and retain towards that goal
September 7, 2018
Medical Device Meritocracy | A Triad of Value
The medical device industry is facing challenging times ahead. A broader set of influencers (regulators, hospital administrators and other value-orientated customers) will see a shift from individual outcomes to a focus on population-led effectiveness and will require the development of comprehensive value propositions for any device or drug.
August 30, 2018
Compliance Considerations in Medical/Commercial Collaborations
In this webinar, we explore two scenarios that can open Medical Affairs up to censure. Scenario one explores participation of commercial team members in Medical Advisory Boards and scenario two looks at the implications of a commercial team member requesting a medical team member to participate in a thought leader meeting.
August 24, 2018
Digital Opinion Leaders: A Challenging Role in a Changing Environment
Who is a Digital Opinion Leader? How to engage a DOL? Harmonize understanding of who a DOL is and the milestones to be considered in the implementation of a DOL initiative; build a well-defined road map to implement a DOL engagement initiative at a local level
July 27, 2018
Real World Data: Unlocking Valuable Insights Throughout the Lifecycle
Real world data (RWD), when captured and analyzed, produces the Real-World Evidence (RWE) that underpins the economic case for innovative medicines. This Webinar aims to provide practical insight into the challenges surrounding RWD and RWE generation with interactive conversation on how individual companies are approaching these challenges.
August 30, 2018
Medical Affairs Excellence and Ethics & Compliance in the Evolving Healthcare Landscape – Collaborating and Leading by Example
This Webinar explores: the role of Medical Affairs in guiding ethical decisions internally and externally; the impact of Medical Affairs beyond its remit; the importance of sharing best practices for the role of Medical Affairs in strategic brand planning, and the ethics and compliance considerations for Medical Affairs plans.
June 29, 2018
Navigating Career Transitions: How to Maximise Your Impact – Without the Burnout
Explore the pitfalls of career transitions, and how to overcome them; look at the key foundations required to make a successful career transition; hear real-life stories, and learn actionable tips, from others who have navigated complex career transitions; explore why health & wellbeing should be a priority on your transition agenda
May 4, 2018
Best Practices for Managing the Life Cycle of an Investigator-Initiated Research (IIR)
This Webinar will discuss the process of investigator initiated research program followed across industry. The process is initiated externally by submission of IIR application via company website followed by internal company review and decision making process. This results in the execution of IIR study contract between the company and the Institution after which the study is initiated by the Investigator.
April 20, 2018
Value Based Contracting & Innovative Payor Engagement for Medical Affairs Professionals, Where is the Market Moving?
This Webinar discusses current trends and anticipated innovations, including the use of outcomes-based agreements; why traditional contracting may not be enough to address the needs of both payers and pharma manufacturers; and insights on the key payer engagement issues you should be considering today to optimize the market success of your products.
March 8, 2018
Patient Centric Real World Data & Evidence Generation
Analysis of RWD leads to clinical evidence known as real world evidence (RWE) regarding the usage and risks and benefits of a therapy. Under the right conditions, RWD and the RWE that follows may be used to support regulatory decisions and contribute to the knowledge of a drug or therapy. RWE may help to support improved decision-making about health and health care.
March 1, 2018
Building Agility into Medical Affairs Strategy: Global-Regional-Local Dynamics
Recognize why networking and alignment is key to a successful Medical Affairs strategic plan; discuss the steps involved in strategic planning process and associated tools and templates; describe Global-Regional-Local alignment and implementation… where do you start? Select which functions you include when building your global Medical Affairs strategy.
January 15, 2018
The Power of Purpose
What do you want this year – to make a difference, to love your work, achieve your targets? Identify the one question top Medical Affairs professionals ask each day; describe the evidence that demonstrates what the most successful people focus on; use a template to create your purpose story
June 24, 2018
Now More Than Ever, HEOR Plays a Central Role in Forging the Modern Healthcare Agenda
Examine the current state & future of HEOR data in healthcare decision-making; discuss strategies to build strong relationships with payers, the medical community, and patient advocacy groups; determine the impact and value of evidence-based pricing and payment